Skip to main content

Table 3 Fatty acid composition of serum, EAT, MAT and SAT of obese CAD group (n = 15) and controls (n = 5)

From: The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease

 

In SERUM

 

In EAT

 

In MAT

 

In SAT

 

Fatty acids

Obese CAD group (n = 15)

Controls (n = 5)

P value

Obese CAD group (n = 15)

Controls (n = 5)

P value

Obese CAD group (n = 15)

Controls (n = 5)

P value

Obese CAD group (n = 15)

Controls (n = 5)

P value

14:0 (myristic acid)

32.7 ± 4.8

32.3 ± 7.9

NS

9.6 ± 0.8

11.9 ± 1.1

NS

10 ± 0.9

9.7 ± 1.4

NS

10.1 ± 0.7

10.4 ± 0.7

NS

16:0 (palmitic acid)

625.2 ± 99.7

419.6 ± 121.3

NS

108.4 ± 7.1

113.9 ± 10

NS

103.7 ± 5.7

98.3 ± 11.8

NS

105.9 ± 7.1

115.6 ± 6.8

NS

16:1n-7 (palmitoleic acid)

67.1 ± 12.6

51.6 ± 12.7

NS

8.3 ± 0.8

14.6 ± 3.3

0.017

8.9 ± 0.8

6.7 ± 2

NS

10.7 ± 1.2

9.8 ± 2.9

NS

18:0 (stearic acid)

182.8 ± 18.3

169.2 ± 22.8

NS

26.5 ± 1.9

24.6 ± 4.5

NS

23.4 ± 1.6

23.9 ± 4.8

NS

22.5 ± 1.9

24 ± 3.6

NS

18:1n-9 (oleic acid)

671.8 ± 115.3

478.4 ± 71.4

NS

168.4 ± 17.5

172.7 ± 13.5

NS

178 ± 14.5

175.9 ± 18.2

NS

201.2 ± 15

217.6 ± 10.4

NS

18:2n-6 (linoleic acid)

834.7 ± 100.9

727.4 ± 104.3

NS

103.2 ± 6.8

105.8 ± 17.6

NS

106.4 ± 5.5

99.1 ± 17.5

NS

118 ± 8.8

117 ± 11.7

NS

18:3n-3 (linolenic acid)

30.2 ± 6.4

23.3 ± 6.6

NS

1.1 ± 0.3

0.4 ± 0.4

NS

0.6 ± 0.2

0.1 ± 0.1

NS

0.6 ± 0.2

0.2 ± 0.2

NS

18:4n-3 (octatetradecanonic acid)

N.D

N.D

NS

2.8 ± 0.3

1.4 ± 0.6

0.026

2.2 ± 0.4

0.3 ± 0.3

0.026

2.1 ± 0.4

2.1 ± 0.8

NS

20:1n-9 (eicosenoic acid)

N.D

N.D

NS

5.9 ± 0.6

5 ± 0.2

NS

6.6 ± 0.6

5.1 ± 0.8

NS

6 ± 0.5

6 ± 0.6

NS

20:3n-6 (eicosatrienoic acid)

40.3 ± 5.6

42.5 ± 8.3

NS

2.0 ± 0.1

1.3 ± 0.4

0.038

1.6 ± 0.2

1.4 ± 0.3

NS

2.2 ± 0.2

2.3 ± 0.6

NS

20:4n-6 (arachidonic acid)

136.8 ± 18

131 ± 19.4

NS

2.5 ± 0.3

1.9 ± 0.5

NS

1.7 ± 0.2

1.6 ± 0.3

NS

2.5 ± 0.3

1.8 ± 0.5

NS

20:5n-3 (eicosapentanoic acid)

N.D

N.D

NS

N.D

N.D

NS

N.D

N.D

NS

0.4 ± 0.3

0.2 ± 0,1

NS

22:5n-3 (dokosapentaenoic acid)

N.D

N.D

NS

1.4 ± 0.3

0.9 ± 0.4

NS

1.2 ± 0.3

0.4 ± 0.2

NS

0.6 ± 0.2

0.4 ± 0.2

NS

22:6n-3 (docosahexaenoic acid)

N.D

N.D

NS

2 ± 0.4

1.3 ± 0.7

NS

2.8 ± 1.7

0.7 ± 0.4

NS

4.4 ± 1.8

1.8 ± 0.6

NS

24:1n-9 (nervonic acid)

25 ± 4.6

33.6 ± 11.4

NS

1.9 ± 0.4

0.6 ± 0.4

NS

1.6 ± 0.4

0.7 ± 0.3

NS

1.6 ± 0.3

1.2 ± 0.4

NS

n-3 (ω − 3)

35 ± 9.5

40.3 ± 9.2

NS

7.5 ± 0.6

4 ± 1.3

0.016

7 ± 1.7

1.6 ± 0.8

NS

8.1 ± 1.9

4.8 ± 0.6

NS

n-6 (ω − 6)

1011.7 ± 115.3

900.9 ± 125.4

NS

107.6 ± 7

109 ± 18.2

NS

109.6 ± 5.7

102 ± 17.7

NS

122.8 ± 9

121.2 ± 12

NS

n-9 (ω − 9)

681.8 ± 116.2

491.8 ± 76.4

NS

176.2 ± 18

178.4 ± 13.9

NS

186.2 ± 15

181.6 ± 19

NS

209 ± 15.2

224.9 ± 10.7

NS

Saturated

840.7 ± 119.9

726.4 ± 107

NS

144.6 ± 9.2

150.3 ± 15.3

NS

137.2 ± 16.9

132 ± 17.7

NS

138.5 ± 9.1

150.1 ± 10.6

NS

Unsaturated

1790.9 ± 237.4

1476.6 ± 205

NS

299.8 ± 20

306 ± 15.3

NS

311.7 ± 16.9

292 ± 36.8

NS

350.4 ± 19

360.5 ± 21

NS

Ratios

16:0 / 16:1

11 ± 1.1

11.1 ± 1.1

NS

14.8 ± 2

10.1 ± 2.7

NS

12.6 ± 0.9

11.8 ± 1.8

NS

11 ± 1

12.6 ± 1.5

NS

18:0 / 18:1

0.3 ± 0.03

0.4 ± 0.05

NS

0.2 ± 0.02

0.14 ± 0.03

NS

0.14 ± 0.02

0.12 ± 0.02

NS

0.11 ± 0.01

0.11 ± 0.01

NS

18:2 / 20:4

6.7 ± 0.7

5.7 ± 0.6

NS

41.3 ± 3.6

47.1 ± 5.6

NS

64.4 ± 6.6

64.5 ± 13.5

NS

49.2 ± 5.3

49.4 ± 4.7

NS

n-6 / n-3

50.3 ± 9.6

24.1 ± 4.4

NS

16.0 ± 1.5

26.8 ± 6.3

0.023

19.5 ± 2.3

43.5 ± 15.4

0.010

19.1 ± 2.3

25.6 ± 4.2

NS

Saturated / Unsaturated

0.5 ± 0.02

0.5 ± 0.02

NS

0.5 ± 0.03

0.5 ± 0.04

NS

0.4 ± 0.02

0.4 ± 0.04

NS

0.4 ± 0.02

0.42 ± 0.03

NS

  1. All values are mean percent of total ± SE. Groups were compared with Mann–Whitney U test for the variables. Significant value, p < 0.05 (Obese CAD group vs. controls). Abbreviations: EAT: epicardial adipose tissue MAT: mediastinal adipose tissue, SAT: subcutaneous adipose tissue.